BioSpace News Archive

Avista Therapeutics , which recently launched as a spinout of leading health system UPMC, aims to develop innovative gene therapies for rare ophthalmic conditions.

908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2022 before market open on Tuesday, August 9, 2022.

ANANDA Scientific Inc., a research-focused bio-pharmaceutical company, announced that Dennis Wong, President and CEO of Baxco Pharmaceutical Inc, has been appointed to ANANDA Scientific’s Board of Directors.

According to Transparency Market Research’s latest report on the global chemiluminescence immunoassay analyzers market for the historical period 2017 - 2018 and forecast period 2019-2027, high incidence & prevalence of chronic diseases to escalate the growth of global chemiluminescence immunoassay (CLIA) analyzers market.

Blood group typing is a process of identifying type of blood that a person has. The process depends on the level of antigens on Red Blood Cells present.

One of the key growth promoting factors for this market is daily stress of life and that keeps on increasing.

The global mammography market is growing at a significant pace, owing to the increasing cancer cases worldwide.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Two major user propositions for deploying healthcare virtual assistants market are their imprint on reducing the burden of care teams and improved patient experience.

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and interim report for January to June 2022.

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the formation of a Medical Advisory Board, and the appointment of Dr. Timothy Wang as its inaugural member.